FDA: Pharmacy's Other Drugs May Be Causing Illness

Health officials have broadened their warning to doctors about other medicines made by a specialty pharmacy linked to a meningitis outbreak.
    
The Food and Drug Administration took the step Monday because of reports of new illnesses that may be tied to other products made by the same company, the New England Compounding Center of Framingham, Mass.
    
Now health officials want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.
    
A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15.
    
The new reports include meningitis in a patient who got another company steroid and fungal infections in two heart transplant patients.

(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Tweet

Related Stories:

• Mass. Firm in Meningitis Case Eyes Bankruptcy Help
• Minn. Records 13th Illness from Tainted Steroids
• Senate Health Chair Wants New Drug Compound Rules
• Owner of Meningitis-Linked Pharmacy Takes Fifth
• Ham Lake Woman Sues After Contracting Meningitis
• Lawmakers Issue Subpoena for Pharmacy Director
• FDA Chief Will Testify at First Meningitis Hearing
• Tests Find Bacteria in Products of Mass. Pharmacy
• Meningitis Outbreak Toll: 377 Illnesses, 29 Deaths
• Mass. Firm Tied to Closed Pharmacy Issues Recall